GLP-1 Coverage & Costs in Rhode Island (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Rhode Island at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Rhode Island Medicaid Coverage for GLP-1
Medicaid: current status not established
KFF counted Rhode Island among the 13 as of January 2026. The RX Index, an independent tracker, reports a weight-loss exclusion scheduled for October 1, 2026. We could not open the state's notice, so we do not state a current answer. Confirm with Rhode Island Medicaid or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
- Source: The RX Index, state tracker, updated September 28, 2026. Read 2026-11-06.
Your Options in Rhode Island:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Rhode Island
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
Rhode Island Medicaid GLP-1 Prescriptions in 2025
46,691
#37
$48.8 million
Ozempic
Rhode Island Medicaid paid for 46,691 GLP-1 prescriptions in 2025, 0.4% of the 11.26 million paid nationally and number 37 of 51 (50 states and DC). It reimbursed pharmacies $48.8 million before manufacturer rebates, about $1,046 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 12,691 of those prescriptions (27.2%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Rhode Island Medicaid GLP-1 prescriptions went from 13,414 to 46,691, 3.5 times the 2021 count. From 2024 to 2025 the count rose by 10,021.
13,414
21,956
32,205
36,670
46,691
| Product | RI Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Ozempic | 21,489 | 46% |
| Mounjaro | 6,951 | 14.9% |
| Wegovy | 6,899 | 14.8% |
| Zepbound | 5,636 | 12.1% |
| Trulicity | 4,072 | 8.7% |
| Rybelsus | 1,291 | 2.8% |
| Liraglutide (generic) | 197 | 0.4% |
| Saxenda | 156 | 0.3% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Rhode Island Employee Plan and Insurer GLP-1 Rules
State of Rhode Island Anchor Plan (active employees)
Does not cover GLP-1s for weight lossRhode Island's Anchor Plan benefit booklet for active state employees, administered by Blue Cross & Blue Shield of Rhode Island, excludes prescribed weight-loss drugs unless they are a listed covered service or come through a program offered with the plan.
The 2026 Anchor Plan benefit booklet lists prescribed weight-loss drugs among its exclusions, with a carve-out for covered services and plan programs.
“Prescribed weight-loss drugs unless included as a covered healthcare service or provided through a program offered with your plan.”
Source: Rhode Island Office of Employee Benefits. Read October 29, 2026.
The same booklet also excludes weight-loss programs unless listed as covered or offered with the plan.
“Programs or drugs designed for the purpose of weight loss, including but not limited to, commercial diet plans, weight loss programs, and any services in connection with such plans or programs, unless listed as a covered healthcare service or offered as a program with your plan.”
Source: Rhode Island Office of Employee Benefits. Read October 29, 2026.
We have no Rhode Islandinsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.
Comparing self-pay programs in Rhode Island?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Rhode Island
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Rhode Island. The rest record a state count without naming the states, so confirm Rhode Island with the program at intake before you pay.
What Programs' Own Pages Say About Rhode Island
7 of the 8 programs whose own pages name the states they serve include Rhode Island: SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Willow does not list Rhode Island. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Rhode Island |
|---|---|
| Willow | Not served RI, per its page |
| SnagRx | Serves RI |
| Strut Health | Ships to RI |
| MangoRx | Ships to RI |
| Wellorithm | Serves RI |
| MEDGm | Serves RI |
| TelosRx | Serves RI |
| Trimi | Serves RI |
Trimi's state table lists Rhode Island as served through the Arora Health network. Visit format there: Online evaluation through the Arora Health network. The telehealth law it cites for Rhode Island is 216-RICR-40-05-1 § 1.5.9(H)(2) (Board of Medical Licensure and Discipline, Licensure and Discipline of Physicians). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Rhode Island
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Rhode Island, 2024
Rhode Island prescribers wrote 67,017 Medicare Part D GLP-1 claims in 2024, number 43 of 51, with $74.8 million in gross drug cost before rebates. Ozempic led with 35,399 claims for 6,147 enrollees. Wegovy had 1,483 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | RI Part D claims | Enrollees |
|---|---|---|
| Ozempic | 35,399 | 6,147 |
| Trulicity | 16,702 | 3,009 |
| Mounjaro | 8,161 | 1,592 |
| Rybelsus | 4,077 | 888 |
| Wegovy | 1,483 | 316 |
| Victoza | 659 | Not given |
| Bydureon Bcise | 367 | 76 |
| Zepbound | 93 | 20 |
| Liraglutide | 51 | 23 |
| Byetta | 25 | Not given |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Rhode Island
The Bridge is national, so the rules are the same in Rhode Island as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Rhode Island Compares to Other New England States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Rhode Island and its neighbors in the New England are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Rhode Island (this page) | Not established | 46,691 |
| Maine | Not covered | 41,655 |
| New Hampshire | Not covered | 34,652 |
| Vermont | Not covered | 17,163 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
If Your Insurance Denies GLP-1 Coverage in Rhode Island
Commercial plans offer an internal appeal, then external review; Rhode Island Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Rhode Island
- Rhode Island Medicaid: Medicaid: current status not established. Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: State of Rhode Island Anchor Plan (active employees), does not cover glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Rhode Island
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Rhode Island.
Frequently Asked Questions — Rhode Island
Does Rhode Island Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Rhode Island Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Rhode Island in 2024?
Does the Rhode Island state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Rhode Island?
Which online GLP-1 programs serve Rhode Island?
Does Medicare cover GLP-1s in Rhode Island?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.